Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 7 of 7 entries
Sorted by: Best Match Show Resources per page
Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock.

Current infectious disease reports

Steigbigel NH.
PMID: 13678564
Curr Infect Dis Rep. 2003 Oct;5(5):363-364. doi: 10.1007/s11908-003-0014-x.

No abstract available.

Cite
Steigbigel NH. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. Curr Infect Dis Rep. 2003;5(5):363-364doi: 10.1007/s11908-003-0014-x.
Steigbigel, N. H. (2003). Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. Current infectious disease reports, 5(5), 363-364. https://doi.org/10.1007/s11908-003-0014-x
Steigbigel, Neal H.. "Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock." Current infectious disease reports vol. 5,5 (2003): 363-364. doi: https://doi.org/10.1007/s11908-003-0014-x
Steigbigel NH. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. Curr Infect Dis Rep. 2003 Oct;5(5):363-364. doi: 10.1007/s11908-003-0014-x. PMID: 13678564.
Copy Download .nbib Format: NLM
The Inevitable and Continual Challenge of Respiratory Infections.

Current infectious disease reports

Steigbigel NH.
PMID: 11095844
Curr Infect Dis Rep. 2000 Apr;2(2):97-99. doi: 10.1007/s11908-000-0019-7.

No abstract available.

Cite
Steigbigel NH. The Inevitable and Continual Challenge of Respiratory Infections. Curr Infect Dis Rep. 2000;2(2):97-99doi: 10.1007/s11908-000-0019-7.
Steigbigel, N. H. (2000). The Inevitable and Continual Challenge of Respiratory Infections. Current infectious disease reports, 2(2), 97-99. https://doi.org/10.1007/s11908-000-0019-7
Steigbigel. "The Inevitable and Continual Challenge of Respiratory Infections." Current infectious disease reports vol. 2,2 (2000): 97-99. doi: https://doi.org/10.1007/s11908-000-0019-7
Steigbigel NH. The Inevitable and Continual Challenge of Respiratory Infections. Curr Infect Dis Rep. 2000 Apr;2(2):97-99. doi: 10.1007/s11908-000-0019-7. PMID: 11095844.
Copy Download .nbib Format: NLM
Recombinant bactericidal/permeability-increasing protein reduced morbidity in children with severe meningococcal sepsis.

Current infectious disease reports

Steigbigel NH.
PMID: 24395477
Curr Infect Dis Rep. 2007 Oct;3(5):405-6. doi: 10.1007/s11908-007-1006-z.

No abstract available.

Cite
Steigbigel NH. Recombinant bactericidal/permeability-increasing protein reduced morbidity in children with severe meningococcal sepsis. Curr Infect Dis Rep. 2007;3(5):405-6doi: 10.1007/s11908-007-1006-z.
Steigbigel, N. H. (2007). Recombinant bactericidal/permeability-increasing protein reduced morbidity in children with severe meningococcal sepsis. Current infectious disease reports, 3(5), 405-6. https://doi.org/10.1007/s11908-007-1006-z
Steigbigel, Neal H. "Recombinant bactericidal/permeability-increasing protein reduced morbidity in children with severe meningococcal sepsis." Current infectious disease reports vol. 3,5 (2007): 405-6. doi: https://doi.org/10.1007/s11908-007-1006-z
Steigbigel NH. Recombinant bactericidal/permeability-increasing protein reduced morbidity in children with severe meningococcal sepsis. Curr Infect Dis Rep. 2007 Oct;3(5):405-6. doi: 10.1007/s11908-007-1006-z. PMID: 24395477.
Copy Download .nbib Format: NLM
Perspective: emerging challenges in the treatment of influenza and parainfluenza in transplant patients.

Advances in virology

Moss RB, Steigbigel RT, Sanders RL, Fang F.
PMID: 22312357
Adv Virol. 2011;2011:910930. doi: 10.1155/2011/910930. Epub 2011 Jul 07.

Influenza, respiratory synctial virus, and parainfluenza are common respiratory infections in immunocompromised transplant recipients, causing significant morbidity and mortality in this patient population. This paper focuses on influenza and parainfluenza virus infections in transplant patients with emphasis on the...

Cite
Moss RB, Steigbigel RT, Sanders RL, et al. Perspective: emerging challenges in the treatment of influenza and parainfluenza in transplant patients. Adv Virol. 2011;2011:910930doi: 10.1155/2011/910930.
Moss, R. B., Steigbigel, R. T., Sanders, R. L., & Fang, F. (2011). Perspective: emerging challenges in the treatment of influenza and parainfluenza in transplant patients. Advances in virology, 2011910930. https://doi.org/10.1155/2011/910930
Moss, Ronald B, et al. "Perspective: emerging challenges in the treatment of influenza and parainfluenza in transplant patients." Advances in virology vol. 2011 (2011): 910930. doi: https://doi.org/10.1155/2011/910930
Moss RB, Steigbigel RT, Sanders RL, Fang F. Perspective: emerging challenges in the treatment of influenza and parainfluenza in transplant patients. Adv Virol. 2011;2011:910930. doi: 10.1155/2011/910930. Epub 2011 Jul 07. PMID: 22312357; PMCID: PMC3265318.
Copy Download .nbib Format: NLM
Dexamethasone treatment in childhood bacterial meningitis in Malawi: a randomized controlled trial.

Current infectious disease reports

Steigbigel NH.
PMID: 12228023
Curr Infect Dis Rep. 2002 Oct;4(5):375-376. doi: 10.1007/s11908-002-0003-5.

No abstract available.

Cite
Steigbigel NH. Dexamethasone treatment in childhood bacterial meningitis in Malawi: a randomized controlled trial. Curr Infect Dis Rep. 2002;4(5):375-376doi: 10.1007/s11908-002-0003-5.
Steigbigel, N. H. (2002). Dexamethasone treatment in childhood bacterial meningitis in Malawi: a randomized controlled trial. Current infectious disease reports, 4(5), 375-376. https://doi.org/10.1007/s11908-002-0003-5
Steigbigel, Neal H.. "Dexamethasone treatment in childhood bacterial meningitis in Malawi: a randomized controlled trial." Current infectious disease reports vol. 4,5 (2002): 375-376. doi: https://doi.org/10.1007/s11908-002-0003-5
Steigbigel NH. Dexamethasone treatment in childhood bacterial meningitis in Malawi: a randomized controlled trial. Curr Infect Dis Rep. 2002 Oct;4(5):375-376. doi: 10.1007/s11908-002-0003-5. PMID: 12228023.
Copy Download .nbib Format: NLM
Clinical Trials Report.

Current infectious disease reports

Steigbigel NH.
PMID: 11559459
Curr Infect Dis Rep. 2001 Oct;3(5):405-406.

No abstract available.

Cite
Steigbigel NH. Clinical Trials Report. Curr Infect Dis Rep. 2001;3(5):405-406
Steigbigel, N. H. (2001). Clinical Trials Report. Current infectious disease reports, 3(5), 405-406.
Steigbigel, Neal H.. "Clinical Trials Report." Current infectious disease reports vol. 3,5 (2001): 405-406.
Steigbigel NH. Clinical Trials Report. Curr Infect Dis Rep. 2001 Oct;3(5):405-406. PMID: 11559459.
Copy Download .nbib Format: NLM
Raltegravir in combination with other antiretroviral agents for the treatment of HIV infection.

Infection and drug resistance

Chirch LM, Steigbigel RT.
PMID: 21694890
Infect Drug Resist. 2010;3:15-23. doi: 10.2147/idr.s9689. Epub 2010 Apr 26.

Raltegravir, an inhibitor of the HIV-1 integrase enzyme, is the first available agent in a new class of antiretroviral drugs. Raltegravir has been studied extensively in clinical trials, and has been well tolerated and highly effective in both treatment-naïve...

Cite
Chirch LM, Steigbigel RT. Raltegravir in combination with other antiretroviral agents for the treatment of HIV infection. Infect Drug Resist. 2010;3:15-23doi: 10.2147/idr.s9689.
Chirch, L. M., & Steigbigel, R. T. (2010). Raltegravir in combination with other antiretroviral agents for the treatment of HIV infection. Infection and drug resistance, 315-23. https://doi.org/10.2147/idr.s9689
Chirch, Lisa M, and Steigbigel, Roy T. "Raltegravir in combination with other antiretroviral agents for the treatment of HIV infection." Infection and drug resistance vol. 3 (2010): 15-23. doi: https://doi.org/10.2147/idr.s9689
Chirch LM, Steigbigel RT. Raltegravir in combination with other antiretroviral agents for the treatment of HIV infection. Infect Drug Resist. 2010;3:15-23. doi: 10.2147/idr.s9689. Epub 2010 Apr 26. PMID: 21694890; PMCID: PMC3108745.
Copy Download .nbib Format: NLM
Showing 1 to 7 of 7 entries